A study linked neck lymph-node removal with later cognitive impairment. Learn what it found and why causation remains unresolved.
On September 29, 2026, Weill Cornell Medicine reported that a study published in Neuron linked removal of neck lymph nodes during head-and-neck cancer treatment with later cognitive impairment.
The study examined cervical lymphadenectomy, an operation that removes nearby lymph nodes in people with head-and-neck cancer. According to Weill Cornell Medicine, researchers brought together patient records and brain imaging with animal experiments to examine cognitive outcomes and a possible biological explanation.
These parts of the research addressed different questions. The records concerned later cognitive impairment. The scans examined changes in brain structure. The animal experiments investigated what might happen when drainage from the brain is suddenly disrupted.
The Weill Cornell report says researchers analyzed records for 1,035 patients at Montefiore Einstein who underwent the procedure without additional chemotherapy or radiotherapy. The analysis was retrospective, meaning the researchers looked back at existing records.
About 18% of patients younger than 65 experienced cognitive impairment within two years of surgery. Among patients older than 65, 25% developed cognitive impairment. The report compared these findings with general-population estimates and described higher rates in the surgical groups.
For older readers, the finding raises a question about cognitive health during recovery from a specific cancer procedure. It also places memory and thinking among the outcomes that researchers are examining after treatment.
A separate group of 59 patients at the Technical University of Munich had brain MRIs before and after surgery. According to Weill Cornell, the scans showed accelerated widening of the ventricular temporal horns. The report describes this as an imaging sign of brain atrophy, or shrinkage.
The imaging change was more pronounced when lymph nodes were removed from both sides of the neck. This provided another observation for researchers to investigate alongside the findings from patient records.
The researchers proposed that removing neck lymph nodes may interfere with cerebrospinal-fluid drainage from the brain. Their working explanation concerns the removal of waste: disruption of this process might affect brain health over time.
Senior author Dr. Laura Santambrogio explained the idea in Weill Cornell’s report:
> “Your body produces lymphatic fluid to wash away waste from every organ, including the brain. If this system is lacking, negative consequences may eventually build up.”
In animal models, the researchers examined sudden disruption of drainage. Weill Cornell reported molecular changes involving oxidative stress and inflammation-related proteins. The researchers also found damage to synapsin, a protein involved in signaling between neurons.
Together, these findings provide a biological question to test further: whether changes in drainage help explain the cognitive outcomes observed after this operation.
The immediate practical value is a reason for a measured conversation during cancer care. For someone facing or recovering from cervical lymph-node removal, the research supports discussing cognitive concerns with the oncology and surgical team.
That conversation can stay focused on the person’s experience rather than the headline alone. Questions might include:
If changes in memory, attention or thinking arise after treatment, patients can tell the team when they began and how they affect daily life. This is a way to communicate concerns clearly. The study did not test symptom reporting as a formal intervention or establish a standard monitoring schedule.
Readers seeking background on this discussion can also read about placing memory concerns in a broader clinical context. Decisions about an individual assessment belong with qualified health professionals who know the person’s care.
The findings are not a reason to avoid or delay cancer treatment. Weill Cornell describes the operation as a way to remove nearby lymph nodes to reduce cancer spread. Questions about the procedure and follow-up should therefore remain part of a discussion with the treating team rather than become a decision made from a news report.
For clinicians and researchers, the practical issue is how cognitive outcomes should be studied alongside cancer treatment. The report identifies a question worth following without supplying a new care protocol.
The reported link between neck lymph-node removal and cognitive decline needs to be read alongside the study’s design. Looking back at patient records can identify an association. Weill Cornell explicitly says further research is needed to confirm a direct link between the surgery and later impairment.
The percentages also require context. They describe outcomes in the studied surgical groups and were compared with general-population estimates. They are not a personal forecast or a calculation of how much surgery alone increased a particular patient’s risk.
The imaging findings and cognitive findings came from separate patient groups. They should not be treated as one set of results showing that every person with cognitive impairment also had the reported MRI change. The scans add another line of evidence, but they do not connect every part of the proposed explanation in the same patients.
The animal results also need a clear boundary. They help researchers investigate a mechanism but do not establish the cause of the patients’ cognitive outcomes. Weill Cornell described the synapsin clumps in the animal findings as different from the amyloid-beta plaques and tau threads typically associated with Alzheimer’s disease. The report does not establish that the operation causes Alzheimer’s disease.
The population matters too. These findings concern people undergoing a specific procedure during head-and-neck cancer treatment. They do not explain ordinary memory changes in older adults who have not had the operation.
Nor did the study establish a supplement, preventive treatment or brain-training approach that reduces this possible risk. Readers interested in that broader subject can review how to assess claims about cognitive training, without treating it as an answer to this surgical finding.
Weill Cornell says the authors plan a prospective study that follows patients over time as they undergo cervical lymph-node removal. That next step would move from looking backward through records to tracking patients as treatment and follow-up occur. The authors identify further research as necessary before a direct link can be confirmed.
This study brings attention to a possible connection between cancer treatment and the systems involved in clearing waste from the brain. Its value lies in joining a clinical observation with imaging and laboratory questions that can now be tested more directly.
For patients, the useful response is to give new thinking or memory concerns a place in conversations with the treating team. For research, the task is to determine whether the observed association reflects a direct effect and how it might occur.
The longer-term significance is not a new prevention routine. It is a more focused research question about cognitive health after a particular cancer procedure. Following that question carefully could improve understanding of brain aging while keeping cancer care and patients’ everyday functioning in view.
A neck-surgery association is not evidence for a protective daily routine; FitBrainLab explains brain-health research without turning early findings into personal health promises. For adults 60+ uncertain about which habits support cognition, its accessible coverage distinguishes established knowledge from open questions about memory and aging.
Follow FitBrainLab for research-led insights on memory, focus, brain aging, nutrition and mental fitness after 60. Stay connected for new articles, practical guidance and ideas for a sharper, more engaged life.
Build habits that support memory, focus and a curious, connected life.
Read the Blog
